ROYLE VENTURES LIMITED

Company number 09000325 ·

Active

Net assets, total assets & total liabilities 2015 – 2024

  • Total assets
  • Net assets
  • Total liabilities
-£1m £0 £1m £2m £3m £4m £5m £6m £7m 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Total assets 2015: £4,383 Total assets 2016: £4,383 Total assets 2017: £4,383 Total assets 2018: £4,383 Total assets 2019: £4,004,308 Total assets 2020: £6,530,627 Total assets 2021: £6,482,746 Total assets 2022: £6,522,078 Total assets 2023: £6,628,653 Total assets 2024: £6,628,255 Total assets Net assets 2015: £200 Net assets 2016: £200 Net assets 2017: £200 Net assets 2018: £200 Net assets 2019: £4,000,125 Net assets 2020: £6,390,656 Net assets 2021: £6,468,136 Net assets 2022: £6,467,295 Net assets 2023: £6,574,020 Net assets 2024: £6,573,572 Net assets Total liabilities 2015: -£4,183 Total liabilities 2016: -£4,183 Total liabilities 2017: -£4,183 Total liabilities 2018: -£4,183 Total liabilities 2019: -£4,183 Total liabilities 2020: -£139,971 Total liabilities 2021: -£13,410 Total liabilities 2022: -£54,183 Total liabilities 2023: -£54,183 Total liabilities 2024: -£54,183 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2023 – 2024

0 0 0 0 0 1 2023 2024 2023: 0 2024: 0

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 10 years

Latest accounts (2024-03-29): Audit exempt.

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2024-03-29 £6,628,255 -£54,183 £6,573,572 0
2023-03-31 £6,628,653 -£54,183 £6,574,020 0
2022-03-31 £6,522,078 -£54,183 £6,467,295
2021-03-26 £6,482,746 -£13,410 £6,468,136
2020-03-26 £6,530,627 -£139,971 £6,390,656
2019-03-31 £4,004,308 -£4,183 £4,000,125 £639,021
2018-03-31 £4,383 -£4,183 £200
2017-03-31 £4,383 -£4,183 £200
2016-03-31 £4,383 -£4,183 £200
2015-03-31 £4,383 -£4,183 £200

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.